Search

everythinglearnresearchcommunity

for

Search:↓

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Diuretics can cause serious side effects and should be used carefully.

New treatments improved blood pressure control in patients with resistant hypertension.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

CTP-543 is generally safe for treating alopecia areata.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Minoxidil quickly leaves blood, turns into urine metabolites, and has lasting blood pressure-lowering effects.

Minoxidil mixed with β-cyclodextrin improves solubility and gradual release.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The new formulation improves dutasteride's absorption when taken orally.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

BMS-470539 reduces skin fibrosis and inflammation.

Some bacteria use arsenic compounds as antibiotics, and others have evolved resistance; a particular arsenic-based compound shows potential as a new antimalarial treatment.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Ixekizumab has known and some unexpected side effects.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.